Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study

Cynthia S. Bonhof; Floortje Mols; M. Caroline Vos; Johanna M. A. Pijnenborg; Dorry Boll; Gerard Vreugdenhil; Nicole P. M. Ezendam; Lonneke V. van de Poll-Franse

doi:10.1016/j.ygyno.2018.03.052

Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study

Cynthia S. Bonhof^*, Floortje Mols, M. Caroline Vos, Johanna M. A. Pijnenborg, Dorry Boll, Gerard Vreugdenhil, Nicole P. M. Ezendam, Lonneke V. van de Poll-Franse

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	455-463
Number of pages	9
Journal	Gynecologic Oncology
Volume	149
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2018.03.052
Publication status	Published - 1 Jun 2018

Keywords

SURVIVORSHIP CARE PLAN
EVERY 3 WEEKS
REPORTED OUTCOMES
1ST-LINE CHEMOTHERAPY
QUESTIONNAIRE MODULE
PROFILES REGISTRY
CLINICAL-PRACTICE
RANDOMIZED-TRIAL
ONCOLOGY-GROUP
ROGY CARE

Access to Document

10.1016/j.ygyno.2018.03.052

Cite this

Bonhof, C. S., Mols, F., Vos, M. C., Pijnenborg, J. M. A., Boll, D., Vreugdenhil, G., Ezendam, N. P. M., & van de Poll-Franse, L. V. (2018). Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study. Gynecologic Oncology, 149(3), 455-463. https://doi.org/10.1016/j.ygyno.2018.03.052

Bonhof, Cynthia S. ; Mols, Floortje ; Vos, M. Caroline ; Pijnenborg, Johanna M. A. ; Boll, Dorry ; Vreugdenhil, Gerard ; Ezendam, Nicole P. M. ; van de Poll-Franse, Lonneke V. / Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study. In: Gynecologic Oncology. 2018 ; Vol. 149, No. 3. pp. 455-463.

@article{41bbe2faa5aa4f8d86979834f10a86a7,

title = "Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study",

keywords = "SURVIVORSHIP CARE PLAN, EVERY 3 WEEKS, REPORTED OUTCOMES, 1ST-LINE CHEMOTHERAPY, QUESTIONNAIRE MODULE, PROFILES REGISTRY, CLINICAL-PRACTICE, RANDOMIZED-TRIAL, ONCOLOGY-GROUP, ROGY CARE",

author = "Bonhof, {Cynthia S.} and Floortje Mols and Vos, {M. Caroline} and Pijnenborg, {Johanna M. A.} and Dorry Boll and Gerard Vreugdenhil and Ezendam, {Nicole P. M.} and {van de Poll-Franse}, {Lonneke V.}",

year = "2018",

month = jun,

day = "1",

doi = "10.1016/j.ygyno.2018.03.052",

language = "English",

volume = "149",

pages = "455--463",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Elsevier Science",

number = "3",

}

Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study. / Bonhof, Cynthia S.; Mols, Floortje; Vos, M. Caroline; Pijnenborg, Johanna M. A.; Boll, Dorry; Vreugdenhil, Gerard; Ezendam, Nicole P. M.; van de Poll-Franse, Lonneke V.

In: Gynecologic Oncology, Vol. 149, No. 3, 01.06.2018, p. 455-463.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study

AU - Bonhof, Cynthia S.

AU - Mols, Floortje

AU - Vos, M. Caroline

AU - Pijnenborg, Johanna M. A.

AU - Boll, Dorry

AU - Vreugdenhil, Gerard

AU - Ezendam, Nicole P. M.

AU - van de Poll-Franse, Lonneke V.

PY - 2018/6/1

Y1 - 2018/6/1

KW - SURVIVORSHIP CARE PLAN

KW - EVERY 3 WEEKS

KW - REPORTED OUTCOMES

KW - 1ST-LINE CHEMOTHERAPY

KW - QUESTIONNAIRE MODULE

KW - PROFILES REGISTRY

KW - CLINICAL-PRACTICE

KW - RANDOMIZED-TRIAL

KW - ONCOLOGY-GROUP

KW - ROGY CARE

U2 - 10.1016/j.ygyno.2018.03.052

DO - 10.1016/j.ygyno.2018.03.052

M3 - Article

C2 - 29605500

VL - 149

SP - 455

EP - 463

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -